The stock slipped 7% to Rs 2,425 on the BSE after the pharmaceutical company said US health regulator issued eight observations after inspecting its formulations plant at Duvvada, Visakhapatnam.
from Latest News https://ift.tt/2P0rckJ
Wednesday, 31 October 2018
Dr Reddy's slips 7% following 8 USFDA observations for Duvvada plant
Subscribe via email
About Unknown
SoraTemplates is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design. The main mission of SoraTemplates is to provide the best quality blogger templates.
Newer Article
Rupee falls 38 paise to 74.06 over strengthening US dollar, RBI-govt rift
Older Article
Sardar Patel unified India in 70 days through bloodless revolution: Rajnath
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment